Arcturus Therapeutics Ltd.

Arcturus Therapeutics Ltd.

Arcturus Therapeutics Ltd.

Date Founded



10628 Science Center Drive,Suite 250,San Diego, CA 92121

Type of Company


Employees (Worldwide)




Company Description

Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA.

Executives & Employees

President & Chief Executive Officer

Chief Financial Officer

Chief Scientific Officer & Chief Operating Officer

Executive Director, Quality & Regulatory Affairs

Director, Head of Investor Relations/Public Relations & Marketing

Senior Director, Pharmaceutical Development

Vice President, Finance & Corporate Controller

Director-Quality & Regulatory Affairs

Associate Director, Drug Discovery

Associate Director, Translational Biology

Board of Directors

Founder at ResMed, Inc.

Chief Financial Officer at Arcturus Therapeutics, Inc.

General Counsel & Executive Vice President at Ultragenyx Pharmaceutical, Inc.

President & Chief Executive Officer at Arcturus Therapeutics Ltd.

Former Executive Director-Pharmaceutical Development at Vical, Inc.

President & Chief Executive Officer at Sanford Consortium For Regenerative Medicine

Former Senior Vice President & Controller at Allergan, Inc.

Paths to Arcturus Therapeutics Ltd.
Potential Connections via
Relationship Science
Arcturus Therapeutics Ltd.
Recent Transactions
Details Hidden

purchases Arcturus Therapeutics Ltd.

Transaction Advisors
Investment Advisor

Advised on purchases Arcturus Therapeutics Ltd.

Advisors & Consultants

Chief Medical Officer at Amplyx Pharmaceuticals, Inc.


Professor, Medicine at University of Pennsylvania - Perelman School of Medicine

Scientific Advisor

Chief Scientific Officer & Chief Operating Officer at Arcturus Therapeutics Ltd.


Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Synthetic Genomics, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.

Key Stats and Financials As of
Market Capitalization
Total Enterprise Value
Earnings Per Share
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Arcturus Therapeutics Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Arcturus Therapeutics Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Arcturus Therapeutics Ltd..